HIV-1 Non-B
Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV 1) RNA bDNA v3 0, Cobas AmpliPrep/Cobas TaqMan HIV 1, and NucliSens HIV 1 EasyQ v1 2, Testing HIV 1 Non B Subtypes and Recombinant Variants
6
Large Scale Analysis of the Prevalence and Geographic Distribution of HIV 1 Non B Variants in the United States
8
Characteristics of Patients Recently Infected with HIV 1 Non B Subtypes in France: a Nested Study within the Mandatory Notification System for New HIV Diagnoses
7
Prevalence of Human Immunodeficiency Virus Type 1 (HIV 1) Non B Subtypes in Foreigners Living in Madrid, Spain, and Comparison of the Performances of the AMPLICOR HIV 1 MONITOR Version 1 0 and the New Automated Version 1 5
5
Characteristics and spread to the native population of HIV 1 non B subtypes in two European countries with high migration rate
12
Prevalence and resistance mutations of non B HIV 1 subtypes among immigrants in Southern Spain along the decade 2000 2010
7
Sensitivity and Specificity of Human Immunodeficiency Virus Rapid Serologic Assays and Testing Algorithms in an Antenatal Clinic in Abidjan, Ivory Coast
5
Most HIV Type 1 Non B Infections in the Spanish Cohort of Antiretroviral Treatment Naïve HIV Infected Patients (CoRIS) Are Due to Recombinant Viruses
7
Epidemiological study of phylogenetic transmission clusters in a local HIV 1 epidemic reveals distinct differences between subtype B and non B infections
9
Seroprevalence of hepatitis B and C virus in HIV 1 and HIV 2 infected Gambians
9
The HIV 1 integrase LEDGF allosteric inhibitor MUT A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity
17
HIV 1 macrophage tropism is determined at multiple levels of the viral replication cycle
10
Low Frequency of CXCR4 Using Viruses in Patients at the Time of Primary Non Subtype B HIV 1 Infection
5
Genotyping of B and Non B Subtypes of Human Immunodeficiency Virus Type 1
5
Utility of a Relatively Affordable In House HIV 1 Genotyping Assay for Drug Resistance Testing among Non B HIV 1 Infected Drug Naive Patients in Nigeria
11
Analysis of a Local HIV 1 Epidemic in Portugal Highlights Established Transmission of Non B and Non G Subtypes
9
High Frequency of Non-B Human Immunodeficiency Virus Type 1 (HIV-1) Subtype Specific Mutations at the Protease Gene among Treatment-naive HIV-1 Infected Individuals in Jos, Nigeria
14
Anti-HIV-1 Activity of Elafin Is More Potent than Its Precursor's, Trappin-2, in Genital Epithelial Cells
12
Comparative Performances of HIV 1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration
7
Rapid Assay for Simultaneous Detection and Differentiation of Immunoglobulin G Antibodies to Human Immunodeficiency Virus Type 1 (HIV 1) Group M, HIV 1 Group O, and HIV 2
5